Pipeline

TVG has established a pipeline of animal vaccines and biotherapeutics to address diseases in animals that have serious commercial impact on livestock production or address major unmet needs in companion animal health.

We have an international network of collaborators and have received funding through a combination of commercial development contracts and grant sponsors,
including the UK, US and Chinese governments. 

Pipeline

Overview of TVG’s current R&D pipeline.

A project by project overview of TVG's pipeline

Funded by commercial animal health companies.

In collaboration with the Pirbright Institute. 

Initially funded by ECO Animal Health and latterly internally funded.

Internally funded.

Internally funded in collaboration with the Pirbright Institute. 

Internally funded.

Internally funded.

Initially internally funded, subsequently funded through BBSRC in collaboration with the Pirbright Institute.

Internally funded.

Internally funded

Internally funded.

Initially funded by Innovate UK and the Chinese government. Latterly internally funded.

Poultry disease

Internally funded in collaboration with a commercial partner.

Canine oncology

Internally funded in collaboration with a commercial partner.